Cannabidiol Terminated Phase 1 Trials for To Provide Further Information About the Potential Need for Sativex Dose Adjustments in Patient Populations Basic Science

IndicationsStatusPurposePhase
TerminatedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02240160A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects